Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Eli Lilly
Eli Lilly
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
Xconomy
Sat, 05/4/19 - 04:54 pm
migraines
CGRP blockers
Aimovig
Amgen
Ajovy
Teva Pharmaceutical
Emgality
Eli Lilly
Faint hope for Alder as Teva bucks dismal migraine trend
EP Vantage
Thu, 05/2/19 - 11:12 am
migraines
Alder Biopharmaceuticals
Teva
Eli Lilly
Amgen
Emgality
Ajovy
eptinezumab
Express Scripts excludes Lilly's low cost insulin generic from preferred formulary
BioCentury
Wed, 05/1/19 - 11:46 pm
Express Scripts
Eli Lilly
insulin
generics
PBMs
Incyte pulls away 'damaged goods' baricitinib to focus on internal pipeline
Endpoints
Tue, 04/30/19 - 08:57 pm
Incyte
olumiant
baricitinib
FDA
Eli Lilly
Eli Lilly misses estimates for top-selling diabetes drug Trulicity, shares slip
Yahoo/Reuters
Tue, 04/30/19 - 09:39 am
Eli Lilly
earnings
Express Scripts excludes Lilly's new low cost insulin generic
BioCentury
Fri, 04/26/19 - 07:40 pm
Express Scripts
Eli Lilly
generics
diabetes
insulin
PBMs
Humalog
As it takes Lartruvo off the shelves, Lilly is setting up program to provide drug access to current patients
Endpoints
Thu, 04/25/19 - 12:00 pm
Eli Lilly
Lartruvo
soft tissue sarcoma
What does the past generation of failure in Alzheimer’s R&D look like in one slide?
Endpoints
Wed, 04/24/19 - 11:45 am
R&D
Alzheimer's disease
amyloid beta
Eli Lilly
Pfizer
JNJ
Lilly to sell legacy antibiotics, Ceclor and Vancocin, to China-based partner in $375M deal
Endpoints
Tue, 04/23/19 - 09:49 am
Eli Lilly
China
antibiotics
Ceclor
Vancocin
Eddingpharm
Safety setback for Pfizer, Lilly pain drug should have Regeneron and Teva feeling nervous
Biopharma Dive
Mon, 04/22/19 - 03:37 pm
Pfizer
Eli Lilly
painkillers
tanezumab
Regeneron
Teva Pharmaceutical
fasinumab
Lilly pays $35M up front to partner with Avidity on oligo conjugates
BioCentury
Mon, 04/22/19 - 10:24 am
Eli Lilly
Avidity
oligo conjugates
Eli Lilly Falls Despite Positive Phase 3 Results From Taltz Study
TheStreet.com
Mon, 04/22/19 - 10:17 am
Eli Lilly
axial spondyloarthritis
clinical trials
Taltz
Pfizer, Lilly to mull anti-NGF mAb's future after joint safety events spike in long-term readout
BioCentury
Fri, 04/19/19 - 05:57 pm
Pfizer
Eli Lilly
tanezumab
BI and Lilly's diabetes drug Jardiance reverses heart failure in animal models
Fierce Biotech
Fri, 04/19/19 - 10:34 am
Eli Lilly
Boehringer Ingelheim
Jardiance
type 2 diabetes
heart failure
Lower dose of Pfizer-Lilly painkiller misses main goals in late stage study
Yahoo/Reuters
Thu, 04/18/19 - 10:35 pm
Pfizer
Eli Lilly
clinical trials
painkillers
osteoarthritis of the knee
tanezumab
The top 15 pharma companies by 2018 revenue
Fierce Pharma
Mon, 04/8/19 - 11:30 pm
JNJ
Roche
Pfizer
Novartis
Merck
GSK
Sanofi
AbbVie
Bayer
Eli Lilly
Amgen
Bristol-Myers Squibb
Gilead Sciences
Teva Pharmaceutical
AstraZeneca
Big Pharma come together for better drug side effect detection
Pharma Times
Sun, 04/7/19 - 05:18 pm
side effects
adverse events
Pfizer
Roche
Takeda
Eli Lilly
Bristol-Myers Squibb
Gilead Sciences
Alexion
Celgene
International Working Group on Signal Detection and Management in Pharmacovigilance
pharmacovigilance
Eli Lilly joins a troika of Big Pharmas that have tied up to a low-profile biotech with big aspirations in autoimmune disease, cancer
Endpoints
Wed, 03/27/19 - 10:24 am
Eli Lilly
ImmunNext
Lilly reveals Humalog pricing details amid larger scrutiny over insulin costs
Biopharma Dive
Mon, 03/25/19 - 10:15 pm
Eli Lilly
drug pricing
Humalog
insulin
diabetes
Lilly's $7M tax abatement in Indianapolis draws bipartisan pushback: reports
Fierce Pharma
Tue, 03/19/19 - 11:36 am
Eli Lilly
taxes
Indiana
Indianapolis
Pages
« first
‹ previous
…
48
49
50
51
52
53
54
55
56
…
next ›
last »